SB 1020

  • Tennessee Senate Bill
  • 113th Regular Session (2023-2024)
  • Introduced in Senate Feb 02, 2023
  • Passed Senate Feb 06, 2023
  • House
  • Governor

Opioids - As introduced, requires a prescribing healthcare practitioner to discuss certain risks associated with a prescribed Schedule II controlled substance prior to an initial prescription and following the third prescription of the drug during a course of treatment; requires the practitioner to document the discussion of such risks in the patient’s medical record. - Amends TCA Title 53 and Title 63.

Bill Subjects

Opioids

Abstract

Bill Sponsors (1)

Votes


No votes to display

Actions


Feb 22, 2023

Senate

Assigned to General Subcommittee of Senate Health and Welfare Committee

Feb 15, 2023

Senate

Placed on Senate Health and Welfare Committee calendar for 2/22/2023

Feb 06, 2023

Senate

Passed on Second Consideration, refer to Senate Health and Welfare Committee

Feb 02, 2023

Senate

Introduced, Passed on First Consideration

Jan 31, 2023

Senate

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.